{"entity":{"type":"insider","cik":"0001570392","url":"/insider/0001570392","json_url":"/insider/0001570392.json","name":"TOMSICEK MICHAEL JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":10,"first":"2013-05-15","last":"2022-10-21","span_basis":"filed_date"},"name_variants":[{"name":"TOMSICEK MICHAEL JOHN","source":"filing","n_filings":10,"first_seen":"2013-05-15","last_seen":"2022-10-21"}],"transactions":[{"id":6787710,"accession":"0001209191-22-054325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054325","line_url":"/filing/0001209191-22-054325#line-1","is_derivative":false,"issuer_cik":"0001408443","issuer_name":"Milestone Pharmaceuticals Inc.","issuer_ticker":"MIST","issuer_name_source":null,"issuer_url":"/issuer/0001408443","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":79800.0,"total_display":"79,800.00","total_whole":"79,800","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-10-21","scope":"insider"},{"id":4670058,"accession":"0001209191-21-050719","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-050719","line_url":"/filing/0001209191-21-050719","is_derivative":false,"issuer_cik":"0001570392","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001570392","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":138.5170544,"price_display":"138.52","price_state":"stated","total_value":3462926.36,"total_display":"3,462,926.36","total_whole":"3,462,926","shares_owned_after":7880.0,"shares_owned_after_display":"7,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-06","filed_date":"2021-08-10","scope":"insider","n_lines":2},{"id":2882463,"accession":"0001209191-20-049430","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-049430","line_url":"/filing/0001209191-20-049430","is_derivative":false,"issuer_cik":"0001570392","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001570392","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":92.25566666666667,"price_display":"92.26","price_state":"stated","total_value":1107068.0,"total_display":"1,107,068.00","total_whole":"1,107,068","shares_owned_after":3210.0,"shares_owned_after_display":"3,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider","n_lines":3},{"id":2900871,"accession":"0001209191-20-045100","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-045100","line_url":"/filing/0001209191-20-045100","is_derivative":false,"issuer_cik":"0001570392","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001570392","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":86.7432108,"price_display":"86.74","price_state":"stated","total_value":1040918.5296,"total_display":"1,040,918.53","total_whole":"1,040,919","shares_owned_after":5858.0,"shares_owned_after_display":"5,858","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider","n_lines":2},{"id":6794081,"accession":"0001127602-14-025788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-14-025788","line_url":"/filing/0001127602-14-025788#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":409.0,"shares_display":"409","price_per_share":63.6754,"price_display":"63.68","price_state":"stated","total_value":26043.2386,"total_display":"26,043.24","total_whole":"26,043","shares_owned_after":6132.0,"shares_owned_after_display":"6,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-18","filed_date":"2014-08-18","scope":"insider"},{"id":6484939,"accession":"0001127602-14-017477","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-14-017477","line_url":"/filing/0001127602-14-017477#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":499.0,"shares_display":"499","price_per_share":69.0,"price_display":"69.00","price_state":"stated","total_value":34431.0,"total_display":"34,431.00","total_whole":"34,431","shares_owned_after":5291.0,"shares_owned_after_display":"5,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-14","scope":"insider"},{"id":6522938,"accession":"0001127602-14-014677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-14-014677","line_url":"/filing/0001127602-14-014677#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":441.0,"shares_display":"441","price_per_share":64.0,"price_display":"64.00","price_state":"stated","total_value":28224.0,"total_display":"28,224.00","total_whole":"28,224","shares_owned_after":4290.0,"shares_owned_after_display":"4,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-16","filed_date":"2014-04-16","scope":"insider"},{"id":6631962,"accession":"0001127602-14-007065","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-14-007065","line_url":"/filing/0001127602-14-007065#line-3","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":555.0,"shares_display":"555","price_per_share":75.0,"price_display":"75.00","price_state":"stated","total_value":41625.0,"total_display":"41,625.00","total_whole":"41,625","shares_owned_after":3370.0,"shares_owned_after_display":"3,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-19","scope":"insider"},{"id":4292466,"accession":"0001127602-13-026697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-13-026697","line_url":"/filing/0001127602-13-026697#line-1","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":64.08,"price_display":"64.08","price_state":"stated","total_value":25632.0,"total_display":"25,632.00","total_whole":"25,632","shares_owned_after":2341.0,"shares_owned_after_display":"2,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-03","filed_date":"2013-09-05","scope":"insider"},{"id":5531278,"accession":"0001127602-13-016941","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-13-016941","line_url":"/filing/0001127602-13-016941#line-2","is_derivative":false,"issuer_cik":"0000912183","issuer_name":"CUBIST PHARMACEUTICALS INC","issuer_ticker":"CBST","issuer_name_source":null,"issuer_url":"/issuer/0000912183","owner_cik":"0001570392","owner_name":"TOMSICEK MICHAEL JOHN","owner_display_name":"TOMSICEK MICHAEL JOHN","owner_url":"/insider/0001570392","role":"Officer (SVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":488.0,"shares_display":"488","price_per_share":49.1791,"price_display":"49.18","price_state":"stated","total_value":23999.4008,"total_display":"23,999.40","total_whole":"23,999","shares_owned_after":1203.0,"shares_owned_after_display":"1,203","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-14","filed_date":"2013-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001408443","name":"Milestone Pharmaceuticals Inc.","url":"/issuer/0001408443","role":"Director","n_filings":1,"first_seen":"2022-10-21","last_seen":"2022-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2020-08-05","last_seen":"2021-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000912183","name":"CUBIST PHARMACEUTICALS INC","url":"/issuer/0000912183","role":"Officer (SVP & Chief Financial Officer)","n_filings":6,"first_seen":"2013-05-15","last_seen":"2014-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001570392","retrieved_at":"2026-08-23T16:18:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}